Pharmacy Online RxYour reliable supplier of generic medications
€0.00 (0 items)Checkout

Categories list

Social bookmarks:

Our billing is certified by:

Secure shopping certificates

Special Offer!

Antivirals

Search by letter:

ABCDEFGHIJKLMNOPQRSTUVWXYZ
 
 
 
Famvir €2.35
Per pill
FamvirFamciclovir 250mg
Buy now!
Lamprene €2.15
Per pill
LampreneClofazimine 50mg
Buy now!
Rebetol €5.88
Per pill
RebetolRibavirin 200mg
Buy now!
Relenza €117.53
Per item
RelenzaZanamivir 5mg
Buy now!
Symmetrel €0.87
Per pill
SymmetrelAmantadine 100mg
Buy now!
Tamiflu €6.82
Per pill
TamifluOseltamivir 75mg
Buy now!
Valtrex €4.13
Per pill
ValtrexValacyclovir 0.5/1g
Buy now!
Zovirax €0.50
Per pill
ZoviraxAcyclovir 200/400/800mg
Buy now!
 
quicksearch
quicksearch

You guys are excellent. Please accept my blessing to your business. )))))))))))))))))))))))))))))))


Moneyback Guarantee
bookmark Bookmark this site
Subscribe to the News

Latest News

  • Public weighs in on pandemic antiviral distribution - CIDRAP

    Public weighs in on pandemic antiviral distributionCIDRAPMay 18, 2012 (CIDRAP News) – The Institute of Medicine (IOM) yesterday shared findings of three public opinion panels on antiviral distribution during a flu pandemic, including a nod for establishing diverse alternative strategies and support for Web .

  • Antiviral research and Neutron Star System behaviours earn BC students ... - Canada NewsWire (press release)

    Antiviral research and Neutron Star System behaviours earn BC students .

  • Broad-Spectrum Antivirals: The Future of HIV Treatment? - TheBody.com

    Broad-Spectrum Antivirals: The Future of HIV Treatment?TheBody.

  • Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs ... - MarketWatch (press release)

    Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs .

  • New Antivirals Show Poor Safety in HCV With Cirrhosis - Medscape

    New Antivirals Show Poor Safety in HCV With CirrhosisMedscapeMay 2, 2012 (Barcelona, Spain) — Two relatively new direct-acting antiviral drugs have poor safety profiles in patients with hepatitis C virus (HCV) and cirrhosis, including a high rate of serious adverse events leading to study discontinuation.